Boston Scientific shared positive data from its MODULAR ATP clinical trial investigating the performance of its Empower leadless pacemaker. Investigators presented data from the MODULAR ATP study at the ESC Congress in London this week. It evaluates the Boston Scientific mCRM (modular cardiac rhythm management) system. The mCRM system features a novel leadless pacemaker (LP) […]
Zimmer Biomet has a new SVP of investor relations
Zimmer Biomet announced today that it appointed David DeMartino as SVP, investor relations. DeMartino reports to President and CEO Ivan Tornos within the leadership structure at the orthopedic giant. His appointment goes into effect on Sept. 9. In this role, DeMartino holds responsibility for developing, refining and leading Zimmer Biomet’s investor relations strategy. He’s also […]
Abbott launches Lingo over-the-counter CGM biosensor in the U.S.
Abbott today announced a major product launch, broadening the population that can utilize its continuous glucose monitoring (CGM) technology. Our sister site, Drug Delivery Business News, reports that Abbott made its Lingo CGM system available without a prescription in the U.S. Lingo features a biosensor and mobile app designed for customers who want to improve their […]
Venus Medtech completes first implants in TAVR study
Venus Medtech announced today that surgeons in China completed the first implants of its transcatheter aortic valve replacement (TAVR) system. The first implant of its Venus-Vitae TAVR system follows the June implants of the VenusP transcatheter pulmonic valve replacement (TPVR) system. Hangzhou, China-based Venus Medtech developed its next-generation, balloon-expandable, dry-tissue TAVR system in-house. Prof. So […]
NeuroPace adds former Boston Scientific DBS marketing head, former Magnus Medical CEO as VPs
NeuroPace (Nasdaq:NPCE) announced today that it appointed Brett Wingeier as its new VP of R&D and Katie Keller as VP of marketing. Both appointments made by the maker of the FDA-approved RNS system for treating epilepsy go into effect immediately. Wingeier’s experience includes a stint as co-founder, CTO and CEO of Magnus Medical, another neurostimulation […]
Report: Judge says Johnson & Johnson must pay Auris shareholders $1B in damages
A Delaware judge ruled that Johnson & Johnson must pay $1 billion in damages to Auris Health shareholders, according to media reports. Reuters, Bloomberg Law, and others report that the ruling claims that J&J breached its agreement to acquire Auris, which went through for $3.4 billion in February 2019. The deal also included up to […]
Renata Medical announces first growth stent implant following FDA approval
Renata Medical announced the first completed implantation of its Minima growth stent for young children after winning FDA approval. Newport Beach, California-based Renata picked up FDA approval for the first-of-its-kind stent last week. The company designed the stent to re-expand over the course of the child’s growth period. “Today marks the beginning of something special,” […]
Fresenius Medical Care launches new home hemodialysis system
Fresenius Medical Care announced today that it launched the newest version of its home hemodialysis (HHD) machine, the NxStage Versi HD with GuideMe software. The new machine features enhancements designed to simplify treatment, increase ease of learning and improve user experience. NxStage Versi HD with GuideMe software picked up FDA clearance in 2023. Fresenius Medical […]
iRhythm enters licensing deal for BioIntelliSense sensor tech
iRhythm Technologies announced today that it signed an exclusive license agreement with BioIntelliSense to develop and commercialize cardiac monitoring technology. The deal centers around certain patented technology assets within ambulatory cardiac monitoring (ACM). iRhythm aims to utilize BioIntelliSense’s multiparameter sensing technologies to expand the capabilities of its own platform. “We believe that the licensed technology […]
Butterfly Network launches next-gen handheld ultrasound in Europe
Butterfly Network announced today that it launched its third-generation handheld point-of-care ultrasound (POCUS) system in Europe. The semiconductor-based, single-probe, whole-body-ultrasound-offering iQ3 features a brand-new ergonomic design and provides double the data processing speed compared to previous generations, according to the company. The FDA cleared the iQ3 system in January and it now has CE mark […]
Abbott initiates study of deep-brain stimulation for treatment-resistant depression
Abbott announced today that it initiated a pivotal clinical trial evaluating its deep-brain stimulation (DBS) system in the treatment of depression. The TRANSCEND study looks at DBS in the management of treatment-resistant depression (TRD), a form of major depressive disorder. Abbott won FDA breakthrough device designation to explore the use of DBS for TRD more […]
